On Mar 28 2014, we issued an updated research report on Avnet Inc. ( AVT ). Avnet had earlier delivered better-than-expected quarterly results, topping the Zacks Consensus Estimate on both counts primarily driven by organic growth across its business segments […]
Qualcomm Inc. ( QCOM ) recently received the regulatory approval in India to divest its remaining stake in Broadband Wireless Access (BWA) spectrum to the local operator Bharti Airtel. In 2010, Government of India conducted a spectrum auction for both 3G network and broadband wireless access. […]
On Mar 29, 2014, Zacks Investment Research upgraded Bemis Company, Inc. ( BMS ) to a Zacks Rank #2 (Buy) from a Zacks Rank #3 (Hold) driven by decent fourth-quarter 2013 results, expected benefits from acquisitions, dividend hike and focus on growth initiatives. Why the Upgrade […]
The Charles Schwab Corp. ( SCHW ), in a recent regulatory filing, announced a hike in chief executive officer (CEO) Walt Bettinger’s remuneration for 2013. […]
ACON Investments Acquires Igloo Products Corp. PR Newswire KATY, Texas, March 31, 2014 KATY, Texas , March 31, 2014 /PRNewswire/ — Igloo Products Corp. […]
Aircastle Announces Closing the Purchase and Leaseback of Four Boeing 777-300ERs with LATAM Airlines Group PR Newswire STAMFORD, Conn., March 31, 2014 STAMFORD, Conn. , March 31, 2014 /PRNewswire/ — Aircastle Limited (“Aircastle” or the “Company”) (NYSE: AYR) announced that it completed the first part of the Company’s previously announced $900 million purchase and leaseback agreement with LATAM Airlines Group S.A. […]
BioLight Announces IND Filing with FDA for Phase I/IIa Clinical Study of its Controlled Release Latanoprost Insert for the Treatment of Glaucoma PR Newswire TEL-AVIV, Israel, March 31, 2014 TEL-AVIV, Israel , March 31, 2014 /PRNewswire/ — BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT; OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned subsidiary, has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to conduct a Phase I/IIa clinical study with its subconjunctival Latanoprost controlled release insert for the treatment of glaucoma. […]
Summit Distribution Completes Acquisition of Adventure 16 Wholesale PR Newswire EAST NORWICH, N.Y., March 31, 2014 EAST NORWICH, N.Y. , March 31, 2014 /PRNewswire/ — Summit Distribution, LLC is pleased to announce that it has completed its acquisition of privately-held San Diego based, Adventure 16’s Wholesale division, a pioneer in the Outdoor Specialty Market since 1962. Adventure 16 Wholesale is one of the largest wholesale distributors specializing in accessories for backpacking, camping, climbing and adventure travel in the United States […]
Vology, Inc. Expands West Coast Services Operations PR Newswire OLDSMAR, Fla., March 31, 2014 OLDSMAR, Fla. , March 31, 2014 /PRNewswire/ — Vology, Inc., a $170 million North American technology solutions provider, has acquired the Irvine, Calif. […]
[marketwatch A33D746E-7357-434A-BF3C-01B1C5BBEE29] Tesla Stock Hits the Skids […]
Zacks Investment Research downgraded shares of EXONE CO/THE (XONE) from NEUTRAL to UNDERPERFORM on March 31, 2014, with a target price of $33.50. The ExOne Company provides three-dimensional printing machines and printed products to industrial customers. The Company also supplies the associated products, including consumables and replacement parts, and services including training and technical support. […]
Zacks Investment Research downgraded shares of UTD CMNTY BK/GA (UCBI) from OUTPERFORM to NEUTRAL on March 31, 2014, with a target price of $21.50. Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day . To get a free copy of the research report on UTD CMNTY BK/GA (UCBI), click here […]
Zacks Investment Research downgraded shares of Tiffany & Company (TIF) from OUTPERFORM to NEUTRAL on March 31, 2014, with a target price of $89.00. Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day . To get a free copy of the research report on Tiffany & Company (TIF), click here . […]
Zacks Investment Research upgraded shares of WORLD POINT TER (WPT) from NEUTRAL to OUTPERFORM on March 31, 2014, with a target price of $22.20. World Point Terminals, LP owns, operates, develops and acquires terminals and other assets relating to the storage of light refined products, heavy refined products and crude oil. The Company's storage terminals are located in the East Coast, Gulf Coast and Midwest regions of the United States […]
Zacks Investment Research upgraded shares of LNB BANCORP INC (LNBB) from NEUTRAL to OUTPERFORM on March 31, 2014, with a target price of $12.00. LNB Bancorp, Inc. […]
Zacks Investment Research upgraded shares of UTD FINL BCP (UBNK) from UNDERPERFORM to NEUTRAL on March 31, 2014, with a target price of $18.70. United Financial Bancorp, Inc. is a publicly owned corporation and the holding company for United Bank, a federally chartered bank […]
Zacks Investment Research upgraded shares of FIVE BELOW INC (FIVE) from UNDERPERFORM to NEUTRAL on March 31, 2014, with a target price of $44.00. Five Below, Inc. […]
Zacks Investment Research upgraded shares of UNIT CORP (UNT) from NEUTRAL to OUTPERFORM on March 31, 2014, with a target price of $66.60. UNIT CORP. […]
Zacks Investment Research upgraded shares of FIDELITY SOUTHN (LION) from UNDERPERFORM to NEUTRAL on March 31, 2014, with a target price of $14.10. Fidelity Southern Corporation, through its operating subsidiary Fidelity Bank, provides a wide range of banking, mortgage and investment services through branches in Atlanta, Georgia. […]
[marketwatch 062AD9AA-25FA-4F2C-ABF2-8E806A53F0B9] Dinner as a Work of Art […]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes